|
State |
Recipient |
Project Title |
Amount |
|---|---|---|---|
|
AL |
Auburn Univ. |
Detection of Prohibited Proteins in Ruminant Feed |
$160,000 |
|
CA |
California Dpt. of Food & Ag. |
Effect of Previously S. Enteritidis Contaminated Environment |
$136,800 |
|
CA |
California Pacific Medical Center |
Gabapentin Therapy in Amyotrophic Lateral Sclerosis |
$118,741 |
|
CA |
Harbor-UCLA Research & Ed. Inst. |
4-Aminopyridine Safety & Efficacy in Spinal Cord Injuries |
$185,052 |
|
CA |
Univ. of California |
Consumer Handling & Washing of Fresh Fruits & Vegetables |
$45,129 |
|
CA |
Univ. of California |
DCA Treatment of Congenital Lactic Academia |
$142,847 |
|
CA |
Univ. of Southern California |
MART Response in Vaccinated Melanoma Patients |
$215,696 |
|
CO |
Colorado State Univ. |
Antimicrobial Use and Resistance in Enteric Bacteria |
$199,382 |
|
DC |
National Food Processors Assoc. |
Surrogates for Evaluating Efficacy of Thermal Processes |
$122,175 |
|
DE |
Delaware Department of Health |
Innovative Inspection Methodologies |
$50,000 |
|
FL |
Florida Department of Health |
Development of Methods for Virus Extraction from Food |
$198,962 |
|
FL |
Florida Dept. of Bus. & Prof. Reg. |
Science-Based Educational Program |
$48,510 |
|
FL |
Univ. of Florida |
Dichloroacetate Treatment of Congenital Lactic Acidosis |
$182,488 |
|
GA |
Univ. of Georgia Research Found. |
Does Antibiotic Usage Create Drug-Resistant Campylobactor |
$195,078 |
|
GA |
Univ. of Georgia Research Found. |
Dose Response Model for Food Borne Listeria |
$338,919 |
|
GA |
Univ. of Georgia Research Found. |
Food borne Protozoa: Inoculation & Inactivation Methods |
$105,173 |
|
GA |
Univ. of Georgia Research Found. |
Non Thermal Method of Enhance Safety of Fresh Produce |
$27,657 |
|
GA |
Univ. of Georgia Research Found. |
Non Thermal Method of Enhance Safety of Fresh Produce |
$132,594 |
|
IA |
Cerro Gordo County Dept. of Health |
North Central Iowa Innovative Food Safety Program |
$47,243 |
|
IA |
Univ. of Iowa |
OK-432 Sclerotherapy - A Multicenter Trial |
$264,558 |
|
IL |
Illinois Institute Technology |
National Center for Food Safety & Technology |
$3,207,093 |
|
IL |
Univ. of Chicago |
GNRH Agonist Therapy of Hypogonadotropism |
$126,038 |
|
IN |
Purdue Research Foundation |
Effect of Inoculation on Efficacy of Chlorine Dioxide Gas |
$104,669 |
|
KS |
Kansas Department of Agriculture |
Bilingual Education Materials to Protect Public Health |
$11,015 |
|
MA |
Aphios Corporation |
Virus Inactivation Device for Medical Devices |
$100,000 |
|
MA |
Boston Univ. |
Arginine Butyrate & Ganciclovir in Epstein Barr Virus |
$163,000 |
|
MA |
Children's Hospital |
Effect Inhaled Nitric Oxide Pediatric Sickle Pain Crisis |
$141,247 |
|
MA |
Curis, Inc. |
Chondrocyte-Alginate Gel Suspension for Pediatric VUR |
$102,400 |
|
MA |
Lincoln Technologies |
Data Mining for Safety Signals in Clinical Data |
$99,783 |
|
MA |
New England Medical Center |
Salmonelia Virulence & Antibiotic Resistance in Cattle/Feed |
$190,219 |
|
MA |
The Children's Hospital, Boston |
Use of Oral Clotrimazole in Sickle Cell Disease |
$253,623 |
|
MA |
Trustees of Boston Univ. |
Phase II Trail of Butyrate for Refractory Sickle Cell Ulcers |
$308,772 |
|
MA |
Tufts Univ. |
Arthritis After Lyme Vaccine |
$30,000 |
|
MA |
Tufts Univ. |
Dose Response Model for Human Crytosporidiosis |
$407,763 |
|
MD |
Johns Hopkins Univ. |
Eff. of Abendazole Therapy in Epilepsy due to Cysticercosis |
$131,041 |
|
MD |
Johns Hopkins Univ. |
Enbrel in Wegener's Granulomatosis Phase II |
$253,912 |
|
MD |
Johns Hopkins Univ. |
Intraventricular Hemorrhage Thrombolysis Trial |
$248,697 |
|
MD |
Kennedy Krieger Research Center |
DHA Therapy of Peroxisomal Disorders |
$306,722 |
|
MD |
Sigma-Tau Pharmaceuticals, Inc. |
Cysteamine Hydrochloride Eye Drops |
$152,746 |
|
MD |
Univ. of Maryland |
Dose Response to Vibrio Species |
$330,828 |
|
State |
Recipient |
Project Title |
Amount
| MD
|
Univ. of Maryland
|
Joint Inst. for Food Safety & Applied Nutrition
|
$3,348,840
|
MI
|
TSRL, Inc.
|
New Device for Drug Dissolution and Absorption Evaluation
|
$98,849
|
MI
|
Univ. of Michigan
|
Prevention of TPN-Cholestasis with Cholecystokinin
|
$215,340
|
MI
|
Univ. of Michigan
|
Therapy of Wilson's Disease with Tetrathiomolybdate
| $276,912
|
MI
|
William Beaumount Hospital
|
Survey of Antimicrobial Resistant Enterococci in Animals
|
$120,849
|
MN
|
Mayo Clinic
|
Vapreotide to Prevent Complications of Pancreatic Resection
|
$141,086
|
MN
|
Olmsted County Public Health Services
|
Risk Factor Eval. & Develop. of Active Managerial Control
|
$40,488
|
MO
|
Jefferson County Health Center
|
Study of Baseline Microbiological Contaminate Levels
|
$50,000
|
MO
|
MetaPhore Pharmaceuticals, Inc.
|
Inactivation of Catecholamines in Septic Shock
|
$100,000
|
MO
|
Washington Univ.
|
Efficacy & Toxicity of Infusional Arsenic Trioxide in APML
|
$155,489
|
NC
|
Duke Univ.
|
Intrathecal Busulfan Therapy of Neoplastic Meningitis
|
$77,000
|
NC
|
North Carolina State Univ.
|
Antimicrobial Resistance of Salmonella Isolated from Swine
|
$118,535
|
NC
|
Univ. of North Carolina
|
Accutane, Cancer Chemoprevention and Dystrophic EB
|
$144,846
|
NC
|
Univ. of North Carolina
|
Alendronate Treatment for Osteoporosis in Cystic Fibrosis
|
$142,526
|
NC
|
Univ. of North Carolina
|
Dev. of Viral Extraction Processing & Detection Methods
|
$170,388
|
NJ
|
Univ. of Medicine & Dentistry
|
Study of Aminopterin for Patients with Acute Lym. Leukemia
|
$214,399
|
NJ
|
Univ. of Medicine & Dentistry
|
Aminopterin in Patients with Refractory Acute Leukemia
|
$135,025
|
NM
|
New Mexico State Univ.
|
WERC Design
|
$100,000
|
NY
|
Columbia Univ.
|
Therapy of Osteoporosis in Men with Parathyroid Hormone
|
$264,642
|
NY
|
Esensors, Inc.
|
Patient Dose Tracking System for Fluoroscopic Procedures
|
$74,437
|
NY
|
Mount Sinai Medical Center
|
Liquid Fluoxetine vs. Placebo in Child Autism
|
$201,752
|
NY
|
Mt. Sinai School of Medicine
|
IL-2 in Common Variable Immunodeficiency
|
$169,500
|
NY
|
Our Lady of Mercy Medical Center
|
Arsenic Trioxide in Leukemia
|
$331,925
|
NY
|
Research Foundation at SUNY
|
Cyclophosphamide to Mycophenolate Mofetil
|
$301,999
|
NY
|
Sloan-Kettering Inst. for Cancer Res.
|
Phase II Trial of Bryostatin-1 & Paclitaxel
|
$325,699
|
NY
|
Sloan-Kettering Inst. for Cancer Res.
|
Rebeccamycin Anal.: A Phase II Study in Neuroblastoma
|
$176,994
|
NY
|
State Univ. of New York
|
Collagenase in the Treatment of Dupuytren's Disease
|
$70,366
|
NY
|
SUNY
|
Vasoctive Intestinal Peptide in the Acute Respiratory Distress
|
$118,050
|
NY
|
Univ. of Rochester
|
Riluzole Dosing in Huntington's Disease
|
$345,915
|
NY
|
Univ. of Rochester Med. Cntr.
|
Mexiletine Treatment of Myotonic Dystrophy
|
$295,565
|
OH
|
Case Western Reserve Univ.
|
Electrical Activation of Diaphragm for Ventilatory Assist
|
$110,522
|
OH
|
Case Western Reserve Univ.
|
Implantable FNS System for Standing Transfers
|
$281,606
|
OH
|
Children's Hospital Medical Center
|
Anti-resorptive Bone Ther. for Osteopenia In Gaucher Disease
|
$248,951
|
OH
|
Children's Hospital Medical Center
|
Multisite Trial of Pergolide in Children with Tourette's
|
$236,757
|
OH
|
Children's Hospital Medical Center
|
Tauroursodeoxycholic Acid Prophylaxis for TPN
|
$144,816
|
OH
|
Univ. of Cincinnati
|
Cultured Skin Substitutes for Closure of Burn Wounds
|
$296,959
|
PA
|
Discovery Labs
|
KL-4 Surfactant-Meconium Aspiration Syndrome
|
$194,390
|
SC
|
Interstate Shellfish Sanitation Conf.
|
Shellfish Safety Assistance Project
|
$320,005
|
SC
|
Medical Univ. of South Carolina
|
Phase II Study of Alendronate in Juvenile Osteoporosis
|
$150,380
|
TN
|
Tennessee State Univ.
|
Home Refrigeration Knowledge and Practices of Consumers
|
$163,632
|
TN
|
Univ. of Tennessee
|
Evaluation and use of BAM
|
$162,643 |
|---|
|
State |
Recipient |
Project Title |
Amount |
|---|---|---|---|
|
TN |
Vanderbilt Univ. Medical Center |
Growth Hormone in Renal Failure |
$187,732 |
|
TX |
Lynntech, Inc. |
Elimination of Pathogens from Fresh Produce |
$100,000 |
|
TX |
Retina Foundation |
DHA Supplementation & X-linked Retinitis Pigmentosa |
$179,060 |
|
TX |
Univ. of Texas Anderson Cancer Center |
Development of ATRAGEN (Liposomal Tretinoin) |
$279,317 |
|
TX |
Univ. of Texas Anderson Cancer Center |
HHT, IFN-A & Ara-C in Early Chronic Myelogenous Leuk. |
$240,577 |
|
TX |
Univ. of Texas Anderson Cancer Center |
Phase II Study of L-NDDP for Malignant Pleural Meso. |
$259,694 |
|
TX |
Univ. of Texas Anderson Cancer Center |
Subcutaneous Homoharringtonine in Chronic Myelogenous Leuk. |
$189,275 |
|
TX |
Univ. of Texas |
Relapsed Acute Promyelocytic Leukemia Patients |
$233,878 |
|
TX |
Univ. of Texas Medical Branch |
Tin Mesoporphyrin and Heme Therapy in Acute Porphyria |
$300,000 |
|
VA |
Lighthouse Instruments LLC |
Validation of a Rapid and Nondestructive Gas Analyzer |
$97,931 |
|
WA |
Children's Hospital & Reg. Med. Cntr. |
Ketorolac in Surgical Infants: Pharmaokinetics/analgesia |
$126,590 |
|
WA |
Children's Hospital & Reg. Med. Cntr. |
TOBI in Young Children with Cystic Fibrosis |
$274,000 |
|
WA |
NeoRx Corporation |
Ho-166-COTMP for Treatment of Multiple Myeloma |
$205,009 |
|
WA |
Wash. State Univ. |
Livestock Feeds as a Means of Dissemination of Antimicrobial |
$188,976 |
|
WA |
Washington State Univ. |
On Farm Risk Factors for Zoonotic Enteropathogens |
$165,050 |
|
WI |
Univ. of Wisconsin |
Natural Variation in Escherichia Coli |
$90,566 |
Total $23,342,304
FDA Home Page | Search | A-Z Index | Site Map | Contact FDA